A three-drug combination for aggressive advanced breast cancer doubles the length of time before the cancer progresses, ...

Cancer Research UK (CRUK) has awarded The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust a ...

A new imaging technique could mean patients with aggressive brain tumours benefit from cutting edge immunotherapy treatments, ...

A pioneering research study which will allow brain cancer patients to access drugs that are precisely targeted to their disease and swap to different treatments if needed, has launched in the UK.

Image: Blood samples in tubes. Doctors could predict whether a man’s prostate cancer will be aggressive at the point of diagnosis – giving him the best targeted treatment quickly before it spreads – ...

Artificial intelligence graphic from Pixabay. Licensed under a CC 0 Creative Commons license. Scientists have used artificial intelligence to predict how cancers will progress and evolve – so that ...

Image: Human breast cancer cells implanted in an experimental animal with two different tracers (red and blue) to investigate the interaction of tumour cells. Credit: Min Yu, National Cancer Institute ...

A combination of two drugs which can block the growth of cancer cells has shown promising results in women with a form of ovarian cancer that rarely responds to chemotherapy or hormone therapy. The ...

Integration of genomics and immunology to study the immune response. This involves high throughput interrogation of tumour antigen and T cell repertoires, and the analysis of mutations and gene ...

The Centre for Immunotherapy of Cancer (CIC), formerly known as the Centre for Translational Immunotherapy (CTI), aims to increase communication between clinicians and scientists with an interest in ...

People with intermediate risk, localised prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower ...